Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance
Go back to Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 73.39 -0.78 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.17 | 52 Week High | $39.41 | |||
| Open | $72.89 | 52 Week Low | $25.98 | |||
| Day High | $73.81 | P/E | 103.37 | |||
| Day Low | $73.17 | EPS | $0.71 | |||
| Volume | 37,645 | |||||
